# Treatment and Exacerbation in COPD Subjects

> **NCT03375450** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 60243 (actual)

## Conditions studied

- Comparative Effectiveness Study

## Interventions

- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03375450
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-09
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 60243 (ACTUAL)
- **Last updated:** 2020-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03375450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03375450, "Treatment and Exacerbation in COPD Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03375450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*